CNH Partners »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by CNH Partners

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by CNH Partners from 13F filings

Historical chart of CNH Partners investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by CNH Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by CNH Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $214k 130k 1.65
2024-09-30 $152k 130k 1.17
2023-12-31 $13M 14M 0.99

More positions owned by CNH Partners

Interpublic Group of Companies (IPG)
Allete Com New (ALE)
Sandstorm Gold Com New (SAND)
Chart Industries (GTLS)
Kellogg Company (K)
Dexcom Note 0.375% 5/1 (Principal)
Air Lease Corp Cl A (AL)
PNM Resources (TXNM)
Cyberark Software SHS (CYBR)
Frontier Communications Pare (FYBR)
Norfolk Southern (NSC)
Akamai Technologies Note 1.125% 2/1 (Principal)
Verona Pharma Sponsored Ads (VRNA)
Liberty Broadband Corp Com Ser C (LBRDK)
Patrick Inds Note 1.750%12/0 (Principal)

View all positions for CNH Partners

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Ing Investment Management
Bnp Paribas Arbitrage, Snc
State Street Corporation
Manufacturers Life Insurance Company
FMR
MacKay Shields
LMR Partners
Parallax Volatility Advisers
Morgan Stanley
BlackRock
Lord, Abbett & Co
Universal- Beteiligungs- und Servicegesellschaft mbH
SSI Investment Management
Jpmorgan Chase & Co
Nicholas Investments Partners

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1